Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1986 2
1987 3
1988 6
1989 4
1990 6
1991 3
1992 8
1993 5
1994 7
1995 6
1996 13
1997 9
1998 15
1999 12
2000 5
2001 10
2002 10
2003 8
2004 17
2005 15
2006 15
2007 9
2008 20
2009 23
2010 14
2011 5
2012 13
2013 18
2014 11
2015 11
2016 23
2017 18
2018 15
2019 24
2020 17
2021 16
2022 9
2023 10
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

405 results

Results by year

Filters applied: . Clear all
Page 1
Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors.
Anthiya S, Öztürk SC, Yanik H, Tavukcuoglu E, Şahin A, Datta D, Charisse K, Álvarez DM, Loza MI, Calvo A, Sulheim E, Loevenich S, Klinkenberg G, Schmid R, Manoharan M, Esendağlı G, Alonso MJ. Anthiya S, et al. Among authors: alonso mj. J Control Release. 2023 May;357:67-83. doi: 10.1016/j.jconrel.2023.03.016. Epub 2023 Mar 28. J Control Release. 2023. PMID: 36921725 Free article.
Editorial note.
Alonso MJ. Alonso MJ. Drug Deliv Transl Res. 2023 Jun;13(6):1543-1545. doi: 10.1007/s13346-023-01340-9. Epub 2023 Apr 18. Drug Deliv Transl Res. 2023. PMID: 37072580 Free PMC article. No abstract available.
Editorial note.
Alonso MJ. Alonso MJ. Drug Deliv Transl Res. 2021 Apr;11(2):331-333. doi: 10.1007/s13346-021-00947-0. Drug Deliv Transl Res. 2021. PMID: 33655442 No abstract available.
New Editor-in-Chief.
Alonso MJ. Alonso MJ. Drug Deliv Transl Res. 2019 Aug;9(4):737. doi: 10.1007/s13346-019-00647-w. Drug Deliv Transl Res. 2019. PMID: 31098929 No abstract available.
Modulating the immune system through nanotechnology.
Dacoba TG, Olivera A, Torres D, Crecente-Campo J, Alonso MJ. Dacoba TG, et al. Among authors: alonso mj. Semin Immunol. 2017 Dec;34:78-102. doi: 10.1016/j.smim.2017.09.007. Epub 2017 Oct 9. Semin Immunol. 2017. PMID: 29032891 Free PMC article. Review.
Oral Delivery of Biologics for Precision Medicine.
Durán-Lobato M, Niu Z, Alonso MJ. Durán-Lobato M, et al. Among authors: alonso mj. Adv Mater. 2020 Apr;32(13):e1901935. doi: 10.1002/adma.201901935. Epub 2019 Jun 20. Adv Mater. 2020. PMID: 31222910 Review.
Polymer-based oral peptide nanomedicines.
Herrero EP, Alonso MJ, Csaba N. Herrero EP, et al. Among authors: alonso mj. Ther Deliv. 2012 May;3(5):657-68. doi: 10.4155/tde.12.40. Ther Deliv. 2012. PMID: 22834409 Review.
Lipid-based nanocarriers for oral peptide delivery.
Niu Z, Conejos-Sánchez I, Griffin BT, O'Driscoll CM, Alonso MJ. Niu Z, et al. Among authors: alonso mj. Adv Drug Deliv Rev. 2016 Nov 15;106(Pt B):337-354. doi: 10.1016/j.addr.2016.04.001. Epub 2016 Apr 11. Adv Drug Deliv Rev. 2016. PMID: 27080735 Review.
Nanotherapies for the treatment of ocular diseases.
Reimondez-Troitiño S, Csaba N, Alonso MJ, de la Fuente M. Reimondez-Troitiño S, et al. Among authors: alonso mj. Eur J Pharm Biopharm. 2015 Sep;95(Pt B):279-93. doi: 10.1016/j.ejpb.2015.02.019. Epub 2015 Feb 26. Eur J Pharm Biopharm. 2015. PMID: 25725262 Review.
405 results